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Initial experimental phases of crystallization process development are commonly carried out at 
very small scales, typically using 1-5mL vessels. The aims of these early phases of process 
development are to select a solvent based on solubility and crystal solid state. These activities are 
commonly conducted in high throughput reactor systems, such as the Crystal16® and Crystalline, 
from Technobis Crystallization Systems, as shown in Figure 1(a) and 1(b), respectively. However, 
for the development, validation and optimization of crystallization process models this data is 
usually not utilized and the selected solution system is probed experimentally and more 
quantitatively at much larger scales, typically between 100 ± 1000 mL. A more quantitative usage 
of the data generated at small scale for the development of process models which may significantly 
reduce the number of larger scale experiments required, would aid in addressing the increasing 
constraints on time and materials in pharmaceutical development. 
Solubility and metastable zone width (MSZW) experiments are routinely conducted with both 
experimental systems, shown in figure 1, with clear points (indicating the point of dissolution) and 
cloud points (indicating the on-set of nucleation in solution) utilised to indicate the MSZW for a 
given cooling rate, agitation rate and solute composition [2]. Through turbidity and temperature 
measurements, both experimental systems provide the ability to quantitatively determine MSZW 
and therefore, the primary nucleation kinetics of the solution system [2, 3]. In addition, the 
Crystalline system also has the added measurement capabilities of particle visualization, providing 
a number based representation of the particle size distribution (PSD), as shown in figure 2, and 
Raman modules for concentration and solid form monitoring. In-situ sizing via image analysis is 
also not prone to sampling issues possible with offline PSD measurements techniques like laser 
diffraction. In addition, the in-situ image analysis capabilities can be enormously beneficial in terms 
of aiding process understanding, providing crucial information for crystallization mechanism and 
model discrimination activities. The lack of probes inserted into the reaction vessel also leads to 
no cross contamination and no interference in the crystallization environment. All of these 
techniques are integrated into a small reactor with overhead stirring and refluxing capabilities, 
which can qualitatively mimic the likely vessel configurations at larger scales. 
 (a)                                                            (b) 
Figure 1: Images of the (a) Crystal16® and (b) Crystalline experimental systems from Technobis Crystallization 
Systems [1]. 
 
 
 
Figure 2: Particle visualization and calculated PSD based on images. 
In this work, data from paracetamol and 3-methyl-1-butanol solutions at the micro-scale was 
utilized to estimate the crystallization kinetics of the model, including crystal growth and primary 
nucleation, enabling model development, as well as mechanism discrimination. The final 
predictions of the developed process model were compared with a previously developed and 
validated process model, which employed larger scale 1 L scale experiments. Cross-validation 
with FBRM, laser diffraction and online solute concentration data from the larger scale, 1 L was 
conducted. Although perfect agreement was not achieved, primarily due to scale and reactor 
dependent kinetic mechanisms, such as primary nucleation and secondary nucleation, the process 
model was in general qualitative agreement with the original model developed with larger scale 
experimental data. A key outcome of this work is an adapted process development workflow for 
the design, model validation and optimization of processing models for crystallization systems. 
This workflow enables crystallization process development with an order of magnitude lower 
demands for materials. In particular raw API, which may not be available in the early stages of 
process development. In addition, the design space for the process can be assessed early on, 
such a process robustness and viability of continuous processing, with less dependence on larger 
scale, more material intensive experiments. As a result, by utilizing commonly available micro-
scale process data the material demands and requirements for larger scale experiments can be 
significantly reduced, leading to a step change in pharmaceutical process development efficiency 
and productivity. 
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